Skip to main content
. Author manuscript; available in PMC: 2005 Sep 13.
Published in final edited form as: J Nucl Med. 2005 May;46(5):807–815.

FIGURE 2.

FIGURE 2

FIGURE 2

(A) Uptake of 99mTc-annexin V-128 in liver and spleen of mice treated with cycloheximide. Groups of six mice were either untreated or treated with cycloheximide (50 mg/kg intraperitoneal). Two hours later, 99mTc-annexin V-128 was injected via the tail vein, and organs were harvested 60 min after the injection. Significance of the difference between treated and untreated animals was assessed by a two-tailed t-test assuming unequal variances; error bars indicate SD. (B) Correlation between TUNEL positivity and 99mTc-annexin V-128 uptake in liver for treated and untreated mice (six in each group).